JAMP TICAGRELOR
As listed in the register: JAMP TICAGRELOR
60 mg · tablet
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Ticagrelor
- Used in
- Blood, clotting and anaemia
- Made by
- Jamp Pharma Corporation
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (ticagrelor). It describes the substance, not this Bulgarian product — its uses and doses can differ.
Ticagrelor and its major metabolite reversibly interact with the platelet P2Y 12 ADP-receptor to prevent signal transduction and platelet activation.
Ticagrelor and its active metabolite are approximately equipotent.
Ticagrelor can be taken with or without food.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-27
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (ticagrelor). It describes the substance, not this Bulgarian product — its uses and doses can differ.
WARNING: BLEEDING RISK Ticagrelor, like other antiplatelet agents, can cause significant, sometimes fatal bleeding ( 5.1, 6.1 ).
- History of intracranial hemorrhage.
- ( 4.1 ) Active pathological bleeding.
- ( 4.2 ) Hypersensitivity to ticagrelor or any component of the product.
Most common adverse reactions (>5%) are bleeding and dyspnea.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States23 matching products
Bulgaria18 matching products
- Krusaxyl 60 mg film - coated tablets standard blisters · film - coated tablets4 makers
- Atixarso 60 mg · film - coated tablets
- KOGAVANT 60 mg · film - coated tablets
- Lacrat 60 mg · film-coated tablets
- Orebriton 60 mg · film - coated tablets
- Plategra 60 mg · film - coated tablets
- Polsar 60 mg · film - coated tablets
- Sophtica 60 mg film-coated tablets · film coated tablet
European UnionNo exact match for this strength and form
Spain31 matching products
- BRILIQUE 60mg · comprimido recubierto con película2 makers
- LACRAT 60 mg · comprimido recubierto con película
- TICAGRELOR ABDI 60 mg · comprimido recubierto con película
- TICAGRELOR ARISTO 60 mg · comprimido recubierto con película
- TICAGRELOR AUROVITAS 60 mg · comprimido recubierto con película
- TICAGRELOR BLUEFISH 60 mg · comprimido recubierto con película
- TICAGRELOR CINFA 60 mg · comprimido recubierto con película
- TICAGRELOR COMBIX 60 mg · comprimido recubierto con película
Netherlands21 matching products
- Ticagrelor Liconsa 60 mg filmomhulde tabletten 60 mg · filmomhulde tablet2 makers
- Ticagrelor Sandoz 60 mg 60 mg · filmomhulde tablet2 makers
- Brilique 60 mg 60 mg · filmomhulde tablet
- Ticagrelor Abdi 60 mg filmomhulde tabletten 60 mg · filmomhulde tablet
- Ticagrelor Accord 60 mg filmomhulde tabletten 60 mg · filmomhulde tablet
- Ticagrelor Amarox 60 mg filmomhulde tabletten 60 mg · filmomhulde tablet
- Ticagrelor Aurobindo 60 mg 60 mg · filmomhulde tablet
- Ticagrelor CF 60 mg 60 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Jamp Pharma Corporation |
|---|---|
| Active substance | Ticagrelor |
| Used in | Blood, clotting and anaemia |
| Strength | 60 mg |
| Form | tablet |
| Classification | B01AC24 · Blood, clotting and anaemia |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02531798 |
| DPD drug code | 102089 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet2 products
- 60 mg
- 90 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.